Clinical Trial Update: A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bioavailability and pharmacokinetics of AZD7594 inhaled via different devices in healthy male subjects; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD7594

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED | Results posted: 2017-06-15